These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9540278)

  • 1. Experimental autoimmune uveitis as animal model for human posterior uveitis.
    Singh VK; Biswas S; Anand R; Agarwal SS
    Indian J Med Res; 1998 Feb; 107():53-67. PubMed ID: 9540278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice.
    Pennesi G; Mattapallil MJ; Sun SH; Avichezer D; Silver PB; Karabekian Z; David CS; Hargrave PA; McDowell JH; Smith WC; Wiggert B; Donoso LA; Chan CC; Caspi RR
    J Clin Invest; 2003 Apr; 111(8):1171-80. PubMed ID: 12697736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental autoimmune uveitis induced by immunization with retinal pigment epithelium-specific 65-kDa protein peptides.
    Nakamura H; Yamaki K; Kondo I; Sakuragi S
    Curr Eye Res; 2005 Aug; 30(8):673-80. PubMed ID: 16109648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease.
    Deeg CA; Thurau SR; Gerhards H; Ehrenhofer M; Wildner G; Kaspers B
    Eur J Immunol; 2002 Sep; 32(9):2598-606. PubMed ID: 12207344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental autoimmune uveoretinitis and pinealitis induced by interphotoreceptor retinoid-binding protein and S-antigen: induction of intraretinal and subretinal neovascularization.
    al-Mahdawi S; McGettrick PM; Lee WR; Graham DI; Shallal A; Converse CA
    J Clin Lab Immunol; 1990 May; 32(1):21-8. PubMed ID: 1726714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin is proinflammatory in experimental autoimmune uveitis.
    Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of retinal autoantigens and their peptides on the inhibition of experimental autoimmune uveitis.
    Dua HS; Abrams MS; Barrett JA; Donoso LA
    Eye (Lond); 1992; 6 ( Pt 5)():447-52. PubMed ID: 1286703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent models of experimental autoimmune uveitis.
    Agarwal RK; Caspi RR
    Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation in uveitis.
    Prasad SA; Gregerson DS
    Eye (Lond); 1997; 11 ( Pt 2)():176-82. PubMed ID: 9349409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
    Kawashima H; Fujiño Y; Mochizuki M
    Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
    Gregerson DS; Obritsch WF; Donoso LA
    J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis.
    Donoso LA; Merryman CF; Sery T; Sanders R; Vrabec T; Fong SL
    J Immunol; 1989 Jul; 143(1):79-83. PubMed ID: 2786534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation of experimental autoallergic uveoretinitis by cyclosporin A withdrawal: an experimental model of uveitis relapse.
    Atkinson EG; Dinning WJ; Kasp E; Graham EM; Dumonde DC
    Clin Exp Immunol; 1989 Oct; 78(1):108-14. PubMed ID: 2805414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
    Eto K; Suzuki S; Singh VK; Shinohara T
    Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.